AnalystsDavid ToungDavid Toung's Stock Forecasts
AnalystsDavid Toung
Analyst Ranking
Top 19%
#797 out of 4119 analysts
Average Return
+4.68%
Win Rate
59%22 out of 37
Risk vs Reward
Poor
Good
David Toung's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mckesson CorpMCK | +56.21% | $196.53 | $307.00 | 2021-03-30 - 2022-03-29 | Strong Buy |
Intuitive Surgical IncISRG | +50.52% | $231.05 | $347.78 | 2020-09-28 - 2021-09-24 | Strong Buy |
Unitedhealth Group IncUNH | +36.91% | $398.81 | $546.01 | 2021-04-21 - 2022-04-20 | Strong Buy |
Johnson & JohnsonJNJ | +33.92% | $123.16 | $164.93 | 2020-03-27 - 2021-03-26 | Strong Buy |
Unitedhealth Group IncUNH | +30.53% | $203.25 | $265.30 | 2017-10-19 - 2018-10-19 | Strong Buy |
David Toung's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Catalent IncCTLT | 1 | Hold | N/A | N/A | Downgrades | 24 days ago |
Mckesson CorpMCK | 2 | Strong Buy | $430.00 | +12.66% | Maintains | 3 months ago |
Unitedhealth Group IncUNH | 3 | Strong Buy | $650.00 | +18.67% | Maintains | 4 months ago |
Amerisourcebergen CorpABC | 1 | Strong Buy | $170.00 | -0.40% | Maintains | 4 months ago |
Gilead Sciences IncGILD | 3 | Strong Buy | $75.00 | -14.61% | Upgrades | 10 months ago |
Zimmer Biomet Holdings IncZBH | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Bristol Myers Squibb CoBMY | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Merck & Co IncMRK | 3 | Strong Buy | $110.00 | N/A | Upgrades | a year ago |
Medtronic PLCMDT | 4 | Strong Buy | $165.00 | N/A | Maintains | a year ago |
Thermo Fisher Scientific IncTMO | 1 | Strong Buy | $600.00 | N/A | Maintains | a year ago |
Teladoc Health IncTDOC | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Bio Techne CorpTECH | 2 | Strong Buy | $490.00 | N/A | Maintains | a year ago |
Intuitive Surgical IncISRG | 2 | Strong Buy | $900.00 | N/A | Maintains | 2 years ago |
Astrazeneca PLCAZN | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Novartis AgNVS | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Abbvie IncABBV | 4 | Strong Buy | $115.00 | N/A | Upgrades | 2 years ago |
Johnson & JohnsonJNJ | 2 | Strong Buy | $155.00 | N/A | Reiterates | 3 years ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $165.00 | N/A | Maintains | 3 years ago |
Wellcare Health Plans IncWCG | 1 | Strong Buy | $360.00 | N/A | Maintains | 4 years ago |
Charles River Laboratories International IncCRL | 1 | Strong Buy | $140.00 | N/A | Maintains | 4 years ago |
Cardinal Health IncCAH | 3 | Strong Buy | $75.00 | N/A | Maintains | 4 years ago |
Celgene CorpCELG | 3 | Hold | N/A | N/A | Downgrades | 5 years ago |
Humana IncHUM | 2 | Strong Buy | $330.00 | N/A | Maintains | 5 years ago |
Amgen IncAMGN | 3 | Strong Buy | $220.00 | N/A | Upgrades | 5 years ago |
Allergan PLCAGN | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Aetna IncAET | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Abbott LaboratoriesABT | 1 | Strong Buy | $62.00 | N/A | Maintains | 5 years ago |
©2022 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactStock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.